A 63-Year-Old Woman With Recurrent Ovarian Cancer

Erin Crane, MD, reviews the case of a 63-year-old woman with recurrent ovarian cancer and discusses treatment options, the Phase 3 NOVA trial, and the future of ovarian cancer treatment.

EP. 1: Case Presentation: A 63-Year-Old Woman With Recurrent Ovarian Cancer

April 14th 2021

Erin Crane, MD, provides an overview of a 63-year-old female patient diagnosed with recurrent ovarian cancer, discussing the initial presentation, clinical work-up, treatment, and her initial impression of the case.

EP. 2: Role of Molecular Testing in Ovarian Cancer

April 14th 2021

An expert in ovarian cancer discusses the role of molecular testing in ovarian cancer and the benefits of incorporating systemic frontline therapy into treatment plans.

EP. 3: Second- and Third-Line Treatment Options for Ovarian Cancer

April 14th 2021

Erin Crane, MD, reviews second- and third-line treatment options and the impact of platinum sensitivity on treatment selection.

EP. 4: Phase 3 NOVA Trial: An Overview

April 14th 2021

Erin Crane, MD, provides an overview of the Phase 3 NOVA trial.

EP. 5: Use of PARP Inhibitors in Recurrent Ovarian Cancer

April 14th 2021

Erin Crane, MD, discusses the role of PARP inhibitors in the treatment of ovarian cancer.

EP. 6: Looking to the Future of Ovarian Cancer Treatment

April 14th 2021

An expert in ovarian cancer considers the future of ovarian cancer treatment, the use of PARP inhibitors and overcoming PARP resistance, and the emerging treatments options.